Teaching the prescriber's role: The psychology of psychopharmacology

被引：28
作者：
David L. Mintz [1 ]
机构：
[1] Department of Psychiatry, Austen Riggs Center, Stockbridge, MA
[2] Austen Riggs Center, Stockbridge, MA 01262
来源：
Academic Psychiatry | 2005年 / 29卷 / 2期
关键词：
Academic Psychiatry; Attachment Style; Borderline Personality Disorder; Psychiatric Resident; Psychiatric Training;
D O I：
10.1176/appi.ap.29.2.187
中图分类号：
学科分类号：
摘要：
Objective: The author examines one aspect of the psychopharmacology curriculum: the psychology of psychopharmacology. Method: Drawing from his experience teaching this subject to trainees at many different levels and from an emerging evidence base suggesting that psychosocial factors in the doctor-patient relationship may be crucial for medication effectiveness, the author explores the importance of this often overlooked aspect of pharmacotherapy. Several methods for teaching the integration of meaning and medication are examined. Results: Generally, residents receiving thorough instruction in the psychology of psychopharmacology believe that they are not only better equipped to integrate psychotherapy and medications, but that this instruction enhances their skills as psychopharmacologists and psychotherapists Conclusion: Teaching the psycho dynamics of psychopharmacology addresses not only residents' needs to become more effective prescribers, but, in part, it may also address predictable developmental crises in residency. Copyright © 2005 Academic Psychiatry.
引用
收藏
页码：187 / 194
页数：7
相关论文
共 29 条
  • [1] Wallerstein R.S., The future of psychotherapy, Bull Menninger Clin, 55, pp. 421-443, (1991)
  • [2] Bluestone H., Clemens N.A., Meyerson A.T., Should clinical training in long-term psychodynamic psychotherapy be mandatory in residency training?, J Psychother Pract Res, 8, pp. 162-169, (1999)
  • [3] Rubin E.H., Zorumski C.F., Psychiatric education in an era of rapidly occurring scientific advances, Acad Med, 78, pp. 351-354, (2003)
  • [4] Mohl P.C., Lomax J., Tasman A., Et al., Psychotherapy training for the psychiatrist of the future, Am J Psychiatry, 147, pp. 7-13, (1990)
  • [5] Docherty J.P., Marder S.R., Van Kammen D.P., Et al., Psychotherapy and pharmacotherapy: Conceptual issues, Am J Psychiatry, 134, pp. 529-533, (1977)
  • [6] Gutheil T.G., The psychology of psychopharmacology, Bull Menninger Clin, 46, pp. 321-330, (1982)
  • [7] Khan A., Warner H.A., Brown W.A., Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: An analysis of the Food and Drug Administration database, Arch Gen Psych, 57, pp. 311-317, (2000)
  • [8] Kirsch I., Moore T.J., Scoboria A., Et al., The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration, Prevention & Treatment, 5, (2002)
  • [9] Ciecanowski P.S., Et al., The patient-provider relationship: Attachment theory and adherence to treatment in diabetes, Am J Psychiatry, 158, pp. 29-35, (2001)
  • [10] Krupnick J.L., Sotsky S.M., Simmens S., Moyer J., Elkin I., Watkins J., Et al., The role of therapeutic alliance in psychotherapy and pharmacotherapy outcome: Findings in the national institute of mental health treatment of depression collaborative research program, J Consult Clin Psychol, 64, pp. 532-1439, (1996)
123